Project Grant R43EY032825

Award Date 9/1/21
Completion Date 8/31/22
Dollars Obligated $881K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
Visionaire Products, Inc. received a $256,000 Project Grant award from the National Science Foundation on February 15, 2021 to complete work by July 31, 2021. The grant was awarded under the NSF's Engineering program (CFDA 47.041) to support development of a novel, microfluidic device to improve collection and analysis of biopsy samples from ocular paracentesis procedures. Specifically, the funding enables Visionaire Products to advance a microfluidic technology designed to more efficiently...
The National Eye Institute (NEI) awarded a $244,015 Project Grant (CFDA 93.867 - Vision Research) to The Research Foundation For The State University Of New York (Upstate Medical Center) to develop a novel "TM/SC-Interface-On-A-Chip" microfluidic platform to investigate dynamic regulation of aqueous humor outflow and its role in glaucoma pathogenesis. The key products and services to be delivered under this grant include: Design and validation of a microfluidic chip-based model that...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 Vision Research) totaling $425,000.00 to the Massachusetts Eye and Ear Infirmary to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The project aims to create a point-of-care metagenomic sequencing platform using the portable Nanopore sequencer to enable timely and accurate diagnosis of ocular infections, reducing the need for...
The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded Retivue LLC a $350,000 Project Grant (R43EY035861) to develop the EntireEyeScope, a high-resolution, stereo endoscopic viewing system for vitreoretinal surgery. The project aims to create a 3D, heads-up, top-down visualization of the retina that closely mimics the traditional surgical view, overcoming limitations of existing ophthalmic endoscopes. This innovative technology is intended to...
This $390,000 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to assess the biomechanical and hydrodynamic effects of different drugs and treatments on modulating outflow facility in the treatment of primary open-angle glaucoma (POAG). The key products and services to be delivered under this 5-year project include: 1) Measuring the velocity of microbeads in the trabecular meshwork (TM) and the elastic moduli of normal...
The federal Project Grant award R43EY037154 from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $306,118 to Eyescreen, Inc. to develop a drug screening platform using functional human donor eyes. The project aims to establish novel ex vivo models for human ocular diseases and develop a high-throughput platform to test the impact of investigational new drugs (INDs) on human retinal neurons and glia under disease-relevant stressors. The goal is to...
The National Eye Institute (NEI) awarded a $257,785 Project Grant under the Vision Research program (CFDA 93.867) to The Leland Stanford Junior University. The grant supports the development of a refillable, microfabricated lens capsule-based drug delivery device for extended intraocular administration of biologics and immune-modulating peptides to treat non-infectious uveitis. The project aims to characterize the release of the biologic drug adalimumab and an immune-modulating peptide from...
The National Eye Institute (NEI) awarded a $713,964 Project Grant under the Vision Research program (CFDA 93.867) to The Regents of the University of California, San Francisco (UCSF). The objective of this 5-year award, effective March 1, 2025, is to develop a prototype of a contact lens-based intraocular pressure (IOP) sensor using atomic force microscopy. The project aims to create an accurate, safe, and wearable IOP monitor that can measure IOP with 0.1-1 mmHg precision, improving the...
This National Eye Institute (NEI) Project Grant award under the Vision Research program (CFDA 93.867) provides $425,000 to the Massachusetts Eye and Ear Infirmary to develop a novel, highly multiplexed diagnostic assay for rapid and accurate detection of pathogens causing serious ocular infections such as keratitis, uveitis, and endophthalmitis. The project aims to leverage advanced NanoString technology to create a panel capable of simultaneously detecting approximately 95% of relevant...
The National Eye Institute awarded the University of Southern California a $443,408 federal Project Grant under the Vision Research program (CFDA 93.867) to develop a novel therapeutic intervention using oxygen nanobubbles to treat retinal ischemia and prevent vision loss. The project aims to: 1) formulate a consistent oxygen nanobubble formulation and evaluate its physical/biochemical properties; 2) identify the optimal administration timing to improve ischemia-induced impairments of retinal...

F Square Medical LLC received a $880,668 Project Grant from the National Eye Institute of the National Institutes of Health, Department of Health and Human Services under the Vision Research federal grant program (CFDA 93.867) for the period of September 1, 2021 through August 31, 2022. The funding will support F Square Medical's development of the first-ever safe and effective anterior chamber paracentesis instrument to treat and diagnose ocular diseases. Specifically, the company will refine the design of its Parasafe instrument prototype, conduct human factors studies, and assess the instrument's functionality with ophthalmologists and an ex vivo porcine model. The Parasafe aims to significantly reduce injury risks associated with current antiquated anterior chamber paracentesis techniques while optimizing the procedure's functionality and advancing this transformative medical device to the next stage of commercialization.

Generated 1/6/24, 4:18 PM